There’s no question about the popularity of GLP-1 weight loss drugs like Ozempic and Wegovy, but some doctors are worried the ...
GLP-1 RA use was associated with significantly lower risk of certain cancers compared with metformin use and insulin use.
HealthDay News — Preoperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is not associated with short-term postoperative aspiration pneumonia, according to a study published online March ...
The following is a summary of “Hematologic Cancers Among Patients With Type 2 Diabetes Prescribed GLP-1 Receptor Agonists,” ...
Despite a crowded GLP-1 drug development field, Structure's oral small molecule approach and strong financial position offer ...
SAN DIEGO, March 23, 2025 — Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss. Unfortunately, shortages and high costs ...
(HealthDay News) — For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist ... to compare the risks for hematologic cancers in patients with T2D treated with a GLP ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback